Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trialSandro Pignata, I. L. Ray-Coquard, Michele Orditura et al.|The Lancet Oncology|2021Cited by 148
Neo-adjuvant and adjuvant chemotherapy of gastric cancerFerdinando De Vita, Michele Orditura, Francesco Giuliani et al.|Annals of Oncology|2007Cited by 63
Phosphatidylinositol 3-kinase (PI3Kα)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cellsFloriana Morgillo, Michele Orditura|Oncotarget|2017Cited by 29
Impact of a Cardio-Oncology Unit on Prevention of Cardiovascular Events in Cancer PatientsAlessandra Cuomo, Carlo G. Tocchetti, Valentina Mercurio et al.|ESC Heart Failure|2022Cited by 22